5 Key Takeaways

• 1

  Historical challenges in women's health significantly impact pharmaceutical development and clinical trial practices.

• 2

  Women have been historically excluded from clinical trials, limiting understanding of drug effects on female patients.

• 3

  The perception of women's health as primarily linked to hormones and reproduction hinders advancements in healthcare.

• 4

  Real-world data could enhance insights into how therapies affect women specifically, addressing healthcare inequalities.

• 5

  There is a need for intentional inclusion in clinical trials to avoid unintentional exclusion of women in drug development.